US2019040055A1PendingUtilityA1

Cycloalkyl-Linked Diheterocycle Derivatives

Assignee: PFIZERPriority: Apr 30, 2014Filed: Oct 11, 2018Published: Feb 7, 2019
Est. expiryApr 30, 2034(~7.8 yrs left)· nominal 20-yr term from priority
A61P 35/00A61P 35/02C07D 417/08C07D 417/14C07D 401/14A61K 31/501A61K 31/427A61K 45/06A61K 31/4439A61K 31/506A61K 31/433C07D 285/135A61K 31/444C07D 277/46
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein A, L, D, R 1 -R 15 , w, x, y, and z are defined herein. The novel cycloalkyl-linked diheterocycle derivatives that are useful in the treatment of abnormal cell growth, such as cancer, in mammals. The present invention also relates to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions in the treatment of abnormal cell growth in mammals.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A compound of structure 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof. 
       
     
     
         2 . A pharmaceutical formulation comprising the compound of  claim 1 , or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier, diluent, or excipient.

Join the waitlist — get patent alerts

Track US2019040055A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.